Table 1.
miRNA | Role | Function | Targets | Reference |
---|---|---|---|---|
Dicer | Function loss | Maturation of microRNAs | miRNAs | [56, 57] [58, 60, 61] |
| ||||
miR-126 | Proangiogenic | Regulates the response of endothelial cells to VEGF | SPRED-1, PIK3R2, VECAM-1, | [64, 68, 71] |
| ||||
miR-221/222 | Antiangiogenic and proangiogenic | Inhibitor of SCF | C-KIT, eNOS, p27 | [73] [61] [74] |
| ||||
miR-17-92 cluster | Proangiogenic and antiangiogenic | Regulation of vascular integrity | THBS1, p21, S1P, JAK1 Flk-1 (VEGFR-2) |
[83] [86] [88] |
| ||||
let-7f; miR-27b | Proangiogenic | ↑EC-mediated angiogenesis | ∗ND | [75] |
| ||||
miR-214 | Antiangiogenic | Tubular sprouting | Quaking | [89] |
| ||||
miR-93 | Proangiogenic | Enhanced endothelial cell activity | LATS2 | [90] |
| ||||
miR-210 | Proangiogenic | Endothelial cell migration and formation of capillaries | Ephrin-A3 | [97] |
| ||||
miR-20b | Antiangiogenic | Decreases levels of HIF1A and VEGF | VEGF, HIF-1α | [102, 103] |
| ||||
miR-21 | Antiangiogenic | Induction of tumour angiogenesis, confers resistance to hypoxia | PTEN, PDCD4, Sprouty1 |
[104] [105] |
| ||||
miR-200 family | Antiangiogenic | Epithelial-mesenchymal transition | ETS-1 | [109] |
| ||||
miR-200c | Antiangiogenic | Epithelial-mesenchymal transition | VEGFR-2 | [110] |
| ||||
miR-107 | Antiangiogenic | Hypoxia signalling | HIF-1β | [111] |
| ||||
miR-519c | Proangiogenic | Depletion of tumour angiogenesis | HIF-1α | [112] |
| ||||
miR-424 | Proangiogenic and antiangiogenic | Destabilization of the E3-ligase assembly, increasing HIF-1α levels | CUL-2 VEGF VEGFR-2 FGFR-1 |
[113] [117] |
| ||||
miR-15a | Antiangiogenic | Control of the cell cycle, apoptosis, proliferation, and angiogenesis | BCL-2 VEGF-A |
[116] |
| ||||
miR-16 | Antiangiogenic | Controls VEGF expression and induces cell apoptosis | VEGF VEGFR-2 FGFR-1 BCL-2 VEGF-A |
[117] [116] |
| ||||
miR-378 | Proangiogenic | Cell survival and tumour growth | SUFU and FUS-1 | [114, 119] |
| ||||
miR-296 | Proangiogenic | Promotes angiogenesis by increasing levels of proangiogenic growth factor receptors | HGS | [120] |
| ||||
miR-199a | Antiangiogenic | Suppresses tumour angiogenesis via the HIF-1α/VEGF pathway | HER3 | [121] |
| ||||
miR-125b | Antiangiogenic | Suppresses tumour angiogenesis via the HIF-1α/VEGF pathway | HER2 HER3 |
[121] |
| ||||
miR-361-5p | Antiangiogenic | Cancer development and progression | VEGF A | [122] |
| ||||
miR-1/206 | Antiangiogenic | Regulation of VegfA expression | VEGF A | [124] |
| ||||
miR-10b | Proangiogenic | Regulation of endothelial cell division and migration | HOXD10, FLT1 | [123] |
| ||||
miR-196b | Proangiogenic | ∗ND | ∗ND | [63] |
| ||||
miR-503 | Antiangiogenic | Overexpression reduces tumour angiogenesis | FGF2, VEGFA | [130] |
| ||||
miR-128 | Antiangiogenic | Decreases cell proliferation, tumour growth, and angiogenesis | P70S6K1 | [131] |
| ||||
mir-145 | Antiangiogenic | Inhibition of tumour growth and angiogenesis | P70S6K1 | [132] |
| ||||
miR-130a | Proangiogenic | Increases angiogenesis by targeting GAX and HOXA5 (antiangiogenic genes) | GAX, HOXA5 | [133] |
| ||||
miR-132 | Proangiogenic | Increases Ras activity | p120RasGAP | [134] |
| ||||
miR-26a | Antiangiogenic | Suppresses tumour growth and metastasis | PIK3C2α
HGF |
[135] [136] |
*ND: not described.